In vitro studies in B16F10 murine melanoma cells showed an increase in calreticulin translocation after therapy, and in vivo studies noted an increase in TNF-α and IL-6 as well as an increase in activated T cell infiltration into primary and metastatic tumors. This evidence concerns the gene CALR and melanoma.